Generate Biomedicines, Inc. (GENB)

NASDAQ: GENB · Real-Time Price · USD

12.29

+0.48 (4.06%)

At close: Mar 19, 2026, 4:00 PM EDT

12.43

+0.14 (1.16%)

After-hours: Mar 19, 2026, 6:58 PM EDT

Generate Biomedicines Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Mar '26 Mar 19, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Capitalization	1,566	-	-
Enterprise Value	1,413	-	-
Debt / Equity Ratio	0.36	0.36	0.22
Net Debt / Equity Ratio	-0.81	-0.81	-0.89
Net Debt / EBITDA Ratio	0.69	0.69	1.74
Net Debt / FCF Ratio	0.75	0.75	2.61
Asset Turnover	0.08	0.08	-
Quick Ratio	2.70	2.70	4.55
Current Ratio	2.85	2.85	4.70
Return on Equity (ROE)	-81.72%	-81.72%	-
Return on Assets (ROA)	-34.63%	-34.63%	-
Return on Capital Employed (ROCE)	-94.80%	-94.80%	-45.60%
Buyback Yield / Dilution	-	-2.77%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q